Enfusion Hits New 52-Week High Should You Buy?
ENFN Stock | USD 10.57 0.05 0.48% |
About 59% of all Enfusion's investors are looking to take a long position. The analysis of the overall prospects from investing in Enfusion suggests that some traders are, at the present time, interested. Enfusion's investing sentiment overview a quick insight into current market opportunities from investing in Enfusion. Many technical investors use Enfusion stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Enfusion |
Enfusion, Inc. hit a new 52-week high during trading on Tuesday . The stock traded as high as 10.78 and last traded at 10.67, with a volume of 16550 shares. The stock had previously closed at 10.62. Analyst Upgrades and Downgrades Separately, Stifel Nicolaus upped their price objective on shares
Read at thelincolnianonline.com
Enfusion Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Enfusion can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Enfusion Fundamental Analysis
We analyze Enfusion's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Enfusion using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Enfusion based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Enfusion is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Enfusion Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Enfusion stock to make a market-neutral strategy. Peer analysis of Enfusion could also be used in its relative valuation, which is a method of valuing Enfusion by comparing valuation metrics with similar companies.
Peers
Enfusion Related Equities
BAINF | BASE | 28.67 | ||||
ROWKF | RenoWorks Software | 12.50 | ||||
PAR | PAR Technology | 1.78 | ||||
RDVT | Red Violet | 1.51 | ||||
ADCOF | Adcore | 8.33 |
Check out Enfusion Hype Analysis, Enfusion Correlation and Enfusion Performance. To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enfusion. If investors know Enfusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enfusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.27) | Earnings Share 0.04 | Revenue Per Share 2.155 | Quarterly Revenue Growth 0.154 | Return On Assets 0.0592 |
The market value of Enfusion is measured differently than its book value, which is the value of Enfusion that is recorded on the company's balance sheet. Investors also form their own opinion of Enfusion's value that differs from its market value or its book value, called intrinsic value, which is Enfusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enfusion's market value can be influenced by many factors that don't directly affect Enfusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enfusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enfusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enfusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.